724
Participants
Start Date
September 30, 2009
Primary Completion Date
May 31, 2011
Levomilnacipran ER
Levomilnacipran ER, 40 mg, oral administration, in capsule form, once daily for 8 weeks.
Levomilnacipran ER
Levomilnacipran ER, 80 mg, oral administration, in capsule form, once daily for 8 weeks.
Levomilnacipran ER
Levomilnacipran ER, 120 mg, oral administration, in capsule form, once daily for 8 weeks.
Placebo
Matching placebo capsules, oral administration, once daily for 8 weeks.
Forest Investigative Site, New York
Forest Investigative Site, New York
Forest Investigative Site, Staten Island
Forest Investigative Site, Mount Kisco
Forest Investigative Site, Brooklyn
Forest Investigative Site, Media
Forest Investigative Site, Norristown
Forest Investigative Site, Rockville
Forest Investigative Site, Baltimore
Forest Investigative Site, Raleigh
Forest Investigative Site, Jacksonville
Forest Investigative Site, Orlando
Forest Investigative Site, Hallandale
Forest Investigative Site, Coral Springs
Forest Investigative Site, West Palm Beach
Forest Investigative Site, Fort Myers
Forest Investigative Site, Memphis
Forest Investigative Site, Canton
Forest Investigative Site, Hoffman Estates
Forest Investigative Site, Wichita
Forest Investigative Site, Dallas
Forest Investigative Site, Dallas
Forest Investigative Site, San Antonio
Forest Investigative Site, Denver
Forest Investigative Site, Phoenix
Forest Investigative Site, Scottsdale
Forest Investigative Site, Beverly Hills
Forest Investigative Site, Sherman Oaks
Forest Investigative Site, Escondido
Forest Investigative Site, Oceanside
Forest Investigative Site, Costa Mesa
Forest Investigative Site, Portland
Forest Investigative Site, Bellevue
Forest Investigative Site, Seattle
Forest Investigative Site, Cromwell
Forest Investigative Site, Cherry Hill
Forest Investigative Site, Willingboro
Forest Investigative Site, Lincoln
Lead Sponsor
Forest Laboratories
INDUSTRY